The 17th Annual Meeting of

Chinese American Pathologists Association

Cherry Blossom Ballroom

Gaylord National Resort & Convention Center

National Harbor, MD

Saturday, March 16th, 1:00- 5:30 PM, 2019

To provide education opportunities, improve professional skills, enhance communication and promote collaboration between CAPA and other pathology organizations.

CAPA serves its members and non-CAPA member pathologists achieve its mission through education, professionalism and connection https://www.capa-ht.org/

Abcarta

AcuPath Laboratories

Dakewe

EastGene Laboratories

e-Century Publishing Corporation

Foundation Medicine

Zu-hua Gao

GoPath

Maixin

Motic

Novodiax

NewPath Diagnostic

OptraScan

SEPA

The Association of Chinese American Physicians

WebPath

Genentech BioOncology

The Key Mission of CAPA

CAPA Acknowledges

the Following Sponsors for Their Support

D ear CAPA members,

Thank you all so much for having given me the privilege to serve you and our beloved society over the past year. Being president of CAPA is a great honor I will carry with me for the rest of my life.

It was an unusual year for each of us since our society experienced a few changes that are necessary to ensure its healthy growth such as reforming CAPA (by forming CAPA-TX and merging CAPA-FL with CAPA-TX) in order to make 501c(3) application more feasible, and amending CAPA Bylaws. It was your unwavering support and trust, your passion, dedication and enthusiasm in making CAPA greater that moved CAPA forward. Incredible support came from the Committee Chairs/EC members and the

CAPA former presidents. I would like to thank you all from the bottom of my heart. You have my deepest respect and admiration.

With our collective effort, we achieved much in the last year and accomplished nearly everything that I pledged to do in the last CAPA business meeting:

1. Amend CAPA Bylaws (Yes)

2. Continue weekly online lectures (Yes)

3. The 4th CAPA Diagnostic Pathology Course in Flushing, New York, August 2018 (Yes)

4. CAPA annual business meeting with pathology updates and group dinner during USCAP at National Harbor, Maryland, March 2019 (Yes)

5. Promote interactions with other pathology societies, both in the U.S. and China (Yes)

6. Co-organize the 4th Sino-US Cancer Diagnostic Pathology Summit (Beijing, China, July 2018) (Yes)

7. Resume CAP companion meeting (Chicago, October 20-24, 2018) (Yes)

8. Promote CAPA Subcommittees and their role in different conferences (Yes)

9. Continue CAPA awards to promote academic excellence for junior members (Yes)

10. Further update or rebuilt CAPA website (Yes)

11. Continue publish CAPA eNewsletter (Yes)

12. Internal review of CAPA finance document, followed by applying 501c(3) status and external auditing. (Yes. We successfully completed internal and external finance reviews by EC and CPA. In 9/2018, we submitted all documents for 501c(3) application to IRS and currently pending for IRS decision.)

13. Promote a healthy CAPA election on the basis of the amended Bylaws (Yes)

14. Continue fund-raising campaign (Yes. A total of $39,700)

I also would like to congratulate the 5 members Drs. Xiaoxian (Bill) Li, Haodong Xu, Huihong Xu, He Wang and Jiehao Zhou for being newly elected Board of Directors. I have full confidence in the new leadership team for their ability to further reinforcing a culture that is essential to the healthy growth and unification of our society (i.e., cohesiveness, inclusiveness, effective communication, and mutual support), and ultimately leading CAPA to a brighter future. Our members are counting on you.

I say goodbye as your president, but I (as a member) will be continuously working with you to forge ahead CAPA’s mission.

Sincerely yours,

Yun Gong, MD

CAPA president 2018-1019

MD Anderson Cancer Center

The CAPA Present’s Annual Report (2018-2019)

Message from President-Elect 2019

D ear Colleagues:

It is a great pleasure and my privilege to serve as CAPA President for 2019-2020. Thank you for your trust and your support. Together with all of you, members of Board of Directors (BOD) and members of Executive Committee (EC), we will continue to honor our excellent traditions from the past and meet challenges of the future.

This year marks the 16th year for CAPA, we are proud of our glorious past thanks to your active participation and

involvement, unwavering love and support. On behalf of the BOD and EC, I would like to express my deepest appreciation and gratitude to all of you including but not limited to all past presidents, EC members, committee and subcommittee chairs, and our sponsors.

Looking ahead, our union is strong, our foundation is solid and our future is therefore bright. Herein I pledge to you that I hold nothing back but work with BOD and EC as hard and close as I can so that we can made sure CAPA continues to be inclusive and representative of all members.

During the next year, as President, I would like to focus on the following areas:

1. First and foremost, working with our attorney we will strive to get the non-for-profit status (501c) approved as soon as possible;

2. Continue to organize and possibly expand our educational activities including annual diagnostic course (Los Angeles, August 2019), ever popular weekly on-line seminars, Sino-American Pathology Summit (Beijing, October 2019), and scientific symposiums at the Annual Business meeting during the USCAP (2020);

3. Expand membership and attract more members;

4. Solicit more sponsorships;

5. Enhance corporation and collaboration with other professional organizations here and abroad such as CAP, USCAP, IAP, and Chinse Society of Pathology (CSP);

6. Any areas you think that are important and beneficial to CAPA members.

To this end, I request you to support me, the BOD and EC as you have graciously done in the past. Together, we can and will make CAPA better and stronger.

Thank you very much. I look forward to working with you.

Huan-You Wang, MD PhD

President of CAPA, 2019-2020

Professor of Pathology

UC San Diego

CAPA Annual Business Meeting and Scientific Session (March 16th, 2019)

Cherry Blossom Ballroom at Gaylord National Resort & Convention Center

1:00-1:20 PM Registration

1:20-1:50 PM Presentations of sponsors: Motic, Foundation Medicine

1:50-3:50 PM Scientific session (see attached program), chaired by Drs. Wei Xin and Huan-You Wang

3:50-4:30 PM Annual reports including reports from Membership/Website Committee and Finance Committees, general CAPA Award presentation, by Drs. Zenggang Pan, Huihong Xu and Yun Gong

4:30-4:50 PM CAPA-GoPath and CAPA-Motic Best Abstract Award Session, presented by Dr. Xiuli Liu with GoPath and Motic representatives

4:50-5:05 PM Speeches by leaders of other Pathology Societies (CAP, CSP, USCAP)

5:05-5:15 PM from the next CAPA President by Dr. Huan-You Wang

5:15-5:30 PM Group Pictures at the conference room

5:30-6:00 PM Bus to the restaurant (Hunan Dynasty, 皇朝)

6:00 PM~ Group dinner (Hunan Dynasty, 215 PENNSYLVANIA AVE SE, WASHINGTON, DC 20003-1155 Tel: 202-5466161)

Time Title Speakers Institution

1:50-2:10 Histological spectrum of heavily treated, metastatic prostatic cancer

Jiaoti Huang, MD, PhD

Duke University

2:10-2:30 Fifty shades of pink: New renal oncocytic tumors

Ming Zhou, MD, PhD

UT South-western University

2:30-2:50 Update of melanocytic lesion George Xu, MD, PhD

University of Pennsylvanian

2:50-3:10 BK polyomavirus associated urothelial carcinoma: cellular origin is critically important in this new entity

Chin-Lee Wu, MD, PhD

Harvard University

3:10-3:15 Q&A

3:15-3:25 NK lymphoma on liver biopsy Lijuan Wang, MD, PhD

Brown University

3:25-3:35 Interesting FNA cases from a patient’s neck and mediastinal lymph nodes

Zhongren Zhou, MD, PhD

Washington University

3:35-3:45 A Case of sarcomatoid carcinoma of urinary bladder

Chunhua Cui, MD

Health Network Labs

3:45-3:50 Q&A

CAPA Awards

CAPA Honorary Award Dr. Ruoqing Huang, is the Regional Director of Cytopathology Services at Elmhurst Hospital Center and Queens Hospital Center, Mount Sinai School of Medicine, and Clinical Associate Professor of SUNY. He received his medical degree from Fujian Medical University, M.S. degree from University of Minnesota, and Ph.D. degree from Mount Sinai School of Medicine, New York. He completed his pathology residency at Cornell University and fellowship training at Mount Sinai Medical Center in New York. Dr. Huang has been a lifetime member of CAPA since 2015 and is an active participant in the organizational activities. His contributions to the organization have been greatly appreciated, and in 2016 he was

awarded "Member of the Year". CAPA has grown rapidly from its humble beginnings, established in 2004 with just dozens of members to now a prominent Chinese American Pathologists Association consisting of hundreds of members. However, due to the organization’s rapid growth and the development of its functions, shortcomings of the organization bylaws and potential problems for long-term development became evident. In light of these problems, a Bylaws Committee was organized to amend the Bylaws with the support of the former CAPA President Ping Tang and President Yun Gong, and approved by the Executive Committee (EC). Dr. Huang was appointed as Chairman of the Bylaws Committee. Under his leadership the Bylaws Committee had set forth rules for discussing its issues and encouraging active participation and debate amongst group members. The minutes of these discussions and opinions were drawn up and voting on final decisions occurred via teleconference. Through the six-month joint effort of all members of the Bylaws committee and the support of the CAPA leadership, the revision to the Bylaws has been completed and approved by CAPA members. The successful amendment of CAPA Bylaws is a significant hallmark for our organization's long-term goals and will also lay a solid foundation for CAPA to become an IRS 501(C)(3) non-profit organization.

CAPA Distinguished Pathologist Award Dr. Youli Zu (祖幼立) completed medical school in China and

obtained PhD in Japan. Subsequently, he received pathology residency training at the New York University and hematopathology fellowship training at the National Cancer Institute of NIH. In 2004, Dr. Zu joined the Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, TX. Currently, he is the Director of Hematopathology Section, the Endowed Chair for Hematopathology Research, and the Director of Cancer Pathology Research Lab at Houston Methodist Hospital. In addition, Dr. Zu is also the Professor appointed at the Weill Cornell Medical College of Cornell University, New York, NY.

As a scientist-physician, Dr. Zu is interested in translational research to immediately improve disease diagnosis and/or precision therapy. His lab has pioneered oligonucleotide aptamer technology development and potential clinical applications. Studies demonstrated the advantages and utilities of synthetic oligonucleotide aptamers for rapid circulating tumor cell detection, specific tissue immunostaining, selective tumor imaging, targeted drug delivery, cancer immunotherapy, and precision nanomedicines. His research was awarded by NIH K22, R01, R21, R33, R41, and R43 grants. In addition, Dr. Zu also received National Innovation Award at the World TechConnect Summit. Currently, he is the principal investigator on NIH R01 and CPRIT research grants. Dr. Zu has published over 120 papers and book chapters in both clinical and biomedical research fields. He has also given over 50 scientific presentations nationally and internationally.

During the past years, Dr. Zu has been actively involved in CAPA activities and played roles in Executive Committees, Election Committee, and CAPA Symposiums. Currently, he is the chair of CAPA Election Committee.

CAPA Awards (cont’d)

CAPA Distinguished Pathologist Award

Dr. Ming Zhou is the Dr. Charles T Ashworth Professor of Pathology and the Director of Anatomic Pathology in the Department of Pathology. He graduated summa cum laude from Fudan University Medical School in Shanghai, China. He completed his pathology residency training at the University of Michigan and a fellowship in the Urological and Kidney Diseases at the Johns Hopkins Hospital. Before moving to UTSW, he was a professor of pathology and urology and the Director of Surgical Pathology at New York

University in New York City.

He has devoted his clinical and research effort to diagnostic urological pathology, and discovery and validation of tumor markers for urological malignancy. He has authored over 170 research articles, 29 review articles and numerous book chapters, and is the editor of 4 textbooks of urological and prostate pathology. He was the co-organizer of the prostate cancer long course at the 2017 USCAP annual meeting. He served on the Cancer Committee of the College of American Pathologists from 2011 to 2017 and is one of the primary authors of the genitourinary cancer protocols, the guidelines for practicing pathologists on diagnosis and reporting genitourinary cancers. He also serves on the editorial board of several pathology journals, including Modern Pathology and Pathology International. Dr. Zhou is actively involved in the Chinese American Pathologists Association (CAPA) and was its president during 2010-2011.

CAPA/Zu-Hua Gao Service Award

Dr. Guoping Cai is currently an Associate Professor of Pathology and Associate Director of Cytopathology at Yale University School of Medicine. He has been an active member of CAPA since 2004. He served as a member of CAPA Executive Committee from 2015 to 2018. He co-chaired the Nominations and Awards Committee from 2015-2017, organizing the yearly abstract call, review and award processes for the CAPA-Motic Best Abstract Award. From 2017 to 2018, he served as the chair of Membership Committee and helped organize 2018 CAPA election and the 3rd CAPA Diagnostic Pathology Course in Chicago. As the

chair of membership committee, he led the verification and reorganization process of CAPA member database, which help facilitate the creation of electronic web-based membership directory. Dr. Cai have actively participated in CAPA-sponsored events and was a speaker at the 1st, 3rd and 4th CAPA Diagnostic Pathology Courses. He was also a team member of CAPA delegations to the Annual Meeting of Chinese Society of Pathology in 2015 and 2017 and to the Sino-US Diagnostic Pathology Summit in 2016.

CAPA Awards (cont’d)

CAPA Member of the Year Award

(in alphabetic order of the last name)

Nominated by the current EC and President for their significant contribution to CAPA activities 2018-2019, including organizing and supporting CAPA diagnostic course and annual business meeting, securing sponsors, CAPA eNewsletters, updating CAPA website, building membership database.

Fan Chen Wen Chen Shaoxiong Chen Lizhen Gui

Xin Han Peng Lee Yingxian (Mark) Liu Ruliang Xu Xiangdong Xu

Ximing Yang Langjing Zhang Xinmin Zhang Chen Zhou

CAPA Awards (cont’d)

CAPA Best Abstract Awards

2019 CAPA-GoPath Best Abstract Award

Award Name Title Institution

1st

place

Yanjun Hou,

MD, PhD

Cytology

fellow

Immunohistochemical comparison of

metaplastic breast carcinoma with

triple negative breast carcinoma

lacking metaplastic features in

relation to checkpoint immune

biomarkers

Cleveland clinic,

OH

2nd

place

Yihe Yang,

MD

Resident

(PGY2)

Is Use of Cancer Protocol Templates

(CAP Synoptics Reports) Associated

with Improved Cancer Patient

Survival? An Exploratory Ecological

Study Using Data from the

Surveillance, Epidemiology, and End

Results (SEER) Program and Public

Searching Engines

Long Island Jewish

Medical Center

/Northshore

University

Hospital, Lake

Success, NY

2rd

place

Feng Yin,

MD, PhD

Adjunct

Clinical

Postdoctoral

Fellow

Splenic arterial involvement is

associated with poor prognosis in

resected distal pancreatic cancer

University of

Florida,

Gainesville, FL

3rd

place

Wei Zheng,

MD, PhD

GI/Liver

Pathology

Fellow

OATP1B3 Is A Novel Immunohisto-

chemical Marker to Discriminate

Well Differentiated Hepatocellular

Carcinoma from Its Benign

Hepatocellular Mimickers

UCLA, Los

Angeles, CA

3rd

place

Lin Zhang,

MD PhD

Resident

(PGY3)

The predictive and prognostic value

of FOXP3+ and FOXP3+/CD25+

regulatory T cells, and PD-L1

expression in triple negative breast

cancer

The University of

Texas Health

Science Center at

Houston, TX

3rd

place

Fengming

Chen, MD,

PhD

Resident

Intraoperative diagnosis of signet

ring cell carcinoma: an 18-year

experience and lesson of a single

institution

Penn State

Health Milton S.

Hershey Medical

Center, Hershey,

PA

3rd

place

Yaohong

Wang, M.D.

Resident

Metal Regulatory Transcription

Factor 1: An Essential Role in

Ovarian Cancer Metastasis and a

Poor Clinical Prognostic Indicator

University of

Tennessee Health

Science Center,

Memphis, TN

Award Name Title Institution

1st

place

Li Zhang Clinicopathological

features of Epstein-Barr

virus infection, micro-

satellite instability, HER2

and PD-L1 expression in

2504 Chinese gastric

Peking University

Cancer Hospital

2nd

place

Mi-die Xu Prognostic value of DNA

repair gene based on

stratification of gastric

cancer

Fudan University

Shanghai Cancer Center

2nd

place

Lu He Tumor mutational burden,

immunoscore and PD-L1

expression in patients with

Epstein-Barr virus-

associated gastric cancer

Department of

Pathology, affiliated

Drum Tower Hospital,

Nanjing

3rd

place

Yufan

Cheng

BCOR rearrangement high

grade endometrial stromal

sarcoma, a potential for

misdiagnosis

Fudan University

Shanghai Cancer Center

3rd

place

Xiang-

Nan Jiang

Epstein-Barr virus-positive

diffuse large B-cell

lymphoma features

disrupted antigen capture

/presentation and hijacked

T-cell suppression

Department of

Pathology, Fudan

University Shanghai

Cancer Center,

Shanghai

3rd

place

Lin Dong Genetic screening of

Lynch syndrome with IHC

pMMR subgroup of

Chinese familial colorectal

cancer patients

National Cancer

Center/National Clinical

Research Center for

Cancer/Cancer Hospital,

Chinese Academy of

Medical Sciences and

Peking Union Medical

College, Beijing

3rd

place

Baowen

Zheng

HPV genotype distribution

of human papillomavirus

in 16054 Chinese women

with abnormal and normal

cervical Pap tests

Kingmed, Guangzhou

CAPA Awards (cont’d) CAPA Best Abstract Awards (Cont’d) 2019 CAPA-Motic Best Abstract Award

Xiaoxian (Bill) Li (李笑闲)

MD, PhD

Emory University

Haodong Xu (徐浩东) MD, PhD

University of Washington Medical Center

Huihong Xu (徐慧红) MD

Boston VA Health Care System

He Wang (王鹤) MD, PhD

Robert Wood Johnson School of Medicine, Rutgers University

Jiehao Zhou (周杰昊) MD, PhD

Indiana University School of Medicine (IUSM)

2019 CAPA Election

Newly Elected Board of Directors

(in alphabetic order of the last name)

The 4th Sino-US Cancer Diagnostic

Pathology Summit Beijing, China, July 2018

Organizing committee: Huan-You Wang, Wei Xin, Yun Gong

Eleven CAPA speakers covering a variety topic in surgical pathology, cytology and hematopathology and there were approximately 200-300 local pathologists

who attended the meeting

Speakers

Guoping Cai, MD Yale University

Zongming Chen, MD, PhD Geisinger Health

Beiyun Chen, MD, PhD Mayo Clinic, MN

Charles Guo, MD, PhD MD Anderson Cancer Institute

Kay Li, MD Johns Hopkins University

Hanlin Wang, MD, PhD University of California, Los Angels

Yanhua Wang, MD, PhD Northwestern University

Wei Xin, MD, PhD Case Western Reserve University

Xiangdong Xu, MD University of California, San Diego

Ximing Yang, MD, PhD Northwestern University

Songlin Zhang, MD University of Texas, Houston

The 4th CAPA Diagnostic Pathology Course

August 25th - 26th, 2018, Flushing, New York

Organizing Committee: Yun Gong, Ximing Yang, Hanlin Wang, Ruliang Xu, Huan-You Wang, Wei Xin, Steven Shen, Lanjing Zhang, Lizhen Gui, Yingxian Liu (Mark), Peng Lee, Huihong Xu, Zongming Chen (Eric)

There were a total of 14.5 AMA PRA Category 1 Credit(s)™

54 faculties, 47 speakers, 201 persons registered to the meeting.

Faculty List (Alphabetically)

Guoping Cai, MD (Yale University)

Beiyun Chen, MD, PhD (Mayo Clinic)

Yihua Chen, MD (Northwestern University)

Zongming Chen (Eric) MD, PhD (Geisinger Medical Center)

Fang-Ming Deng, MD, PhD (NYU School of Medicine)

Fang Fan, MD, PhD (University of Kansas)

Jerald Z Gong, MD (Thomas Jefferson University)

Yun Gong, MD (MD Anderson Cancer Center)

Lizhen Gui, MD, PhD (Northwest Arkansas Pathology Associates)

Jiaoti Huang, MD, PhD (Duke University)

Pei Hui, MD, PhD (Yale University)

Peng Lee, MD, PhD (NYU)

Faqian Li, MD, PhD (University of Minnesota)

Feng Li, MD, PhD, JD (Medical Examiner’s Office, Davidson County and Metropolitan Nashville)

Shaoying Li, MD (MD Anderson Cancer Center)

Xiaoxian Li (Bill), MD, PhD (Emory University)

Fan Lin, MD, PhD (Geisinger Medical Center)

Jingmei Lin (Indiana University School of Medicine)

Pei Lin, MD (MD Anderson Cancer Center)

Chen Liu, MD, PhD (Robert Wood Johnson Medical School, Rutgers University)

Jinsong Liu, MD, PhD (MD Anderson Cancer Center)

Xiuli Liu, MD, PhD (University of Florida Health)

Yingxian Liu (Mark), MD (Brooklyn Hospital, NY)

Zenggang Pan, MD, PhD (University of Colorado)

Steven Shen, MD, PhD (Houston Methodist Hospital/Cornell University)

Xiaoping Sun, MD, PhD (MD Anderson Cancer Center)

Beverly Wang, MD (UC Irvine)

Hanlin Wang, MD, PhD (UCLA)

He Wang, MD, PhD (Robert Wood Johnson Medical School, Rutgers University)

Jun Wang, MD (Loma Linda University)

Sa Wang, MD (MD Anderson Cancer Center)

Yanhua Wang, MD (Montefiore Medical Center/Albert Einstein College of Medicine)

Jianjun Wei, MD (Northwestern University)

Sang Wu, MD (Texas Health Presbyterian Hospital)

Wei Xin, MD, PhD (Case Western Reserve University)

Haodong Xu, MD, PhD (University of Washington)

Huihong Xu, MD, MS (Boston University)

Ruliang Xu, MD, PhD (NYU Langone Medical Center)

Hongyu Yang (Henry) MD, PhD (St Vincent Evansville Hospital, Evansville, IN)

Hua Yang, MD (University of Calgary)

Jack Yang, MD (Medical University of South Carolina)

Ximing Yang, MD, PhD (Northwestern University)

JinJuan Yao, MD, PhD (Memorial Sloan Kettering Cancer Center)

Limin Yu, MD (Beaumont Health Care)

Lanjing Zhang, MD, MS (Princeton HealthCare System/Rutgers University)

Miao Zhang, MD, PhD (MD Anderson Cancer Center)

Xinmin Zhang, MD (Cooper University Hospital, New Jersey)

Xuchen Zhang, MD, PhD (Yale University)

Yaxia Zhang, MD, PhD (Hospital for Special Surgery, Weill-Cornell School of Medicine, NY)

Wenxin Zheng, MD (UT Southwestern Medical Center)

Minghao Zhong, MD (New York Medical College)

Ming Zhou, MD, PhD (UT Southwestern Medical Center)

The 4th CAPA Diagnostic Pathology Course

August 25th - 26th, 2018, Flushing, New York (Cont’d)

CAPA/CAP Companion Meeting

Chicago, October 20th - 24th, 2018

Organizing Committee: Yun Gong (Chair), Wei Xin (co-chair),

Huanyou Wang, Hanlin Wang, Zenggang Pan, Huihong Xu

Speakers:

Wei Xin, MD, PhD Case Western Reserve University

Longwen Chen, MD, PhD Mayo Clinic

Yingbei Chen, MD,PhD Memorial Sloan-Kettering

Xiaoqi Lin, MD, PhD Northwestern University

Jiehao Zhou, MD, PhD Indiana University

Online Pathology Course

Led by Dr. Zenggang Pan and Dr. Linsheng Zhang

Timeframe: 01/14/2017 - 02/17/2019

Total Lectures: 82, including 13 special topics

Total Speakers: 61

Total Registers: 808 (as of 01/29/2019)

Average Attendees: 263 each lecture

Organizing Chairs: Drs. Zenggang Pan, Linsheng Zhang.

Online Course Speakers:

Shuting Bai, Lihong Bu, Guoli Chen, Xueyan Chen, Yi Ding, Yanan Fang,

Baojin Fu, Yumei Fu, Shunyou Gong, Wei Jiang, Xin Jing, Michael Klein,

Xiangtian (Max) Kong, Zaibo Li, Xiaoxian (Bill) Li, Rong Li, Xiaoqi Lin,

Xiuli Liu, Liping Liu, Xiaoying Liu, Dan Lu, Changqing (Cathy) Ma, Zeng-

gang Pan, Xiaohua Qian, Jingxin Qiu, Qinghu Ren, Zhiyong Ren, Rulong

Shen, Qiuying Shi, Yang Shi, Wei Wang, Huanyou Wang, Min Wang, Dehua

Wang, Shi Wei, Xiaojun Wu, Wei Xin, Deyin Xing, Henry Yang, Hua Yang,

Huaitao Yang, Jinjuan Yao, Limin Yu, Wendong Yu, Zhongxin Yu,

Youzhong Yuan, Ji (Jane) Yuan, Jianying Zeng, Jim Zhai, Xuchen Zhang,

Chen Zhang, Yaxia Zhang, Linsheng Zhang, Qianyun Zhang, Qing (Grace)

Zhao, Xiangrong Zhao, Gang Zheng, Ming Zhou, Yi Zhou, Jiehao Zhou, Hui

Zhu

Chairs of CAPA Committees 2018-2019

Ruoqing Huang

(Bylaws)

Youli Zu

(Election)

Fan Chen

(Newsletter)

Xiuli Liu

(Award,

Secretary of EC)

Zenggang Pan

(Membership/Website)

Huihong Xu

(Finance)

Wei Xin

(Education)

Huan-You Wang

(Education)

Feng Li

(Career,

Private Practice)

Lihong Bu, Marilyn Bui, Silvia Bunting, Jianping Cai, Qing Chang, Baorong Chen, Fan Chen, Guilan Chen, Hannah Chen, Helen Chen, Hui Chen, Longwen Chen, Ning Chen, Sheng Chen, Wei Chen, Xiangbai Chen, Yan Chen, Yayan Chen, Yi-hua Chen, Zongming Chen, Hong Cheng, Liang Cheng, Lin Cheng, Ningli Cheng, Chunhua Cui, Wei Cui, Qian Dai, Qingqing Ding, Xiuzhen Duan, Fang Fan, Rong Fan, Sean Fan, Wei Feng, Liying Fu, Guofeng Gao, John Gao, Zu-huanGao, Lan Gellert, Ping Gong, Yulan Gong, Yun Gong, Yan Gu, Lizhen Gui, Charles Guo, Huimin Guo, Xiaoling Guo, Liying Han, Xueli Hao, Gang He, Wei Hong, Peihong Hsu, Huankai Hu, Jun Hu, Lulin Hu, Qinglong Hu, Jack Huang, Jiaoti Huang, Qin Huang, Ruoqing Huang, Wei Huang, Pei Hui, Peng Ji, Hongchen Jia, Ming Jiang, Yuying Jiang, Ming Jin, Ni Jin, Xin Jing, Peng Lee, Junyi Lei, Cuizhen Li, Faqian Li, Feng Li, Guiyuan Li, Hongmei Li, Jian Yi Li, Jinhong Li, Lin Li, Long Li, Shaoying Li, Victoria Li, Weihong Li, Xin Li, Yanhua Li, Yanping Li, Yanxia Li, Zaibo Li, Zujin Li, Mei Liang, Songlin Liang, Guanghong Liao, Xiaoyan Liao, Fan Lin, Jingmei Lin, Yuan Lin, Chen Liu, Fang Liu, Haiyan Liu, James Liu, Jiafan Liu, Jinli Liu, Jinsong Liu, Jun Liu, Shaojun Liu, Weiguo Liu, Wendy Liu, Wenhua Liu, Xiuli Liu, Ying Liu, Yingxian Liu, Yunguang Liu, Xiaolin Liu-jarin, Danielle Lu, Frank Luo, Pifu Luo, Xiaoling Ma, Zhiwei Ma, Joan Mao, Jun Mo, Kai Ni, Xingcao Nie, Guilian Niu, Jie Ouyang, Zenggang Pan, Zhiheng Pei, Yue Peng, Yingchao Piao, Robert Pu, Fang Qian, Junqi Qian, Jingxin Qiu, Rulong Ren, Zhiyong Ren, June (Youjun) Shen, Steven Shen, Jinru Shia, Jie Song, Mu Su, Daisy Sun, Jianlan Sun, Wei Sun, Xiaoping Sun, Farah Tabassum, Dongfeng Tan, Dan-iel Tang, Wozhan Tang, Wei Tian, Emily Volk, Beverly Wang, Cheng Wang, Dehua Wang, Fengwei Wang, Gang Wang, Hanlin Wang, He Wang, Hongling Wang, Huamin Wang, Huan-you Wang, Jun Wang, Lan Wang, Larry Wang, Li juan Wang, Lina Wang, Ling Wang, Lu Wang, Min Wang, Steven Wang, Wenjing Wang, Wenle Wang, Xi Wang, Xiaoqiong Wang, Yanhua Wang, Yihong Wang, Eric Wei, Jianjun Wei, Fang Wen, Baoy-ing Weng, Chinlee Wu, Jamie Wu, Sang Wu, Yihui Wu, Donglin Xie, Wei Xin, Bo Xu, Chengen Xu, Gang Xu, Huihong Xu, Ruliang Xu, Xiangdong Xu, Xiaomeng (Karen) Xu, Shirley Yan, Bin Yang, Dingming Yang, Guangyu Yang, Hongyu (Henry) Yang, Jian Yang, Ximing Yang, Xuebin Yang, Jinjuan Yao, Xu Yao, Huihui Ye, Chunhui Yi, Hong Yin, Xiao-ming Yin, Hongbo Yu, Limin Yu, Qihui Zhai, Dahua Zhang, David Zhang, Dongwei Zhang, Haiyan Zhang, Jing Zhang, Jun Zhang, Lanjing Zhang, Lizhi Zhang, Sha-ron Zhang, Songlin Zhang, Wei Zhang, Xiaohong Zhang, Xinmin Zhang, Yan Zhang, Yanhong Zhang, Yaxia Zhang, Zesong Zhang, Bihong Zhao, Bin Zhao, Chengquan Zhao, Huicong Zhao, Qing Zhao, Song Zhao, Xiangrong Zhao, Xiaohui Zhao, Rui Zheng, Su Zheng, Tim Zheng, Wenxin Zheng, Hua Zhong, Jin Zhong, Minghao Zhong, Weixiong Zhong, Chen Zhou, Fan Zhou, Jiehao Zhou, Ming Zhou, Ting Zhou, Weidong Zhou, Zhon-gren Zhou, Bing Zhu, Lee-ching Zhu, Yi Zhuang, Youli Zu

CAPA Lifetime Members (261, in Alphabetic Order)

Chin-Lee Wu (2001-2005)

Ximing Yang (2006)

Bin Yang (2007)

Su-Yuan Xiao (2008)

Shuan Li (2009)

Ming Zhou (2010)

Steven Shen (2011)

Zu-Hua Gao (2012)

Jinsong Liu (2013

Qihui (Jim) Zhai (2014)

Fan Lin (2015)

Huamin Wang (2016)

Ping Tang (2017)

CAPA Past Presidents

CAPA Acknowledges the Following Sponsors for Their Support

The 4

th CA

PA

Diag

nostic P

atholo

gy C

ourse at F

lush

ing, N

ew Y

ork

, Au

gu

st 25

-26

th, 2018

(Pho

tograp

hed

by D

r. Xiao

pin

g S

un)